New York, NY
Dr. Raja M. Flores
Chief, Thoracic Surgery
New York University - 1988
Albert Einstein College of Medicine - 1992
Columbia-Presbyterian Medical Center
Brigham and Women's Hospital in Boston/Dana Farber Cancer Institute
Overview and Educational Background
Considered a leading expert in the study and treatment of malignant pleural mesothelioma, Dr. Raja M. Flores, is Chief of Thoracic Surgery at The Mount Sinai Medical Center in New York. A graduate of New York University, where he received a bachelor's degree in biology, and the Albert Einstein College of Medicine in the Bronx, NY, Flores completed both a general surgery internship and general surgery residency at Columbia-Presbyterian Medical Center in New York City. He also earned a Thoracic Oncology Clinical Research Fellowship at Brigham and Women's Hospital in Boston/Dana Farber Cancer Institute and completed an additional residency in cardiothoracic surgery at Brigham and Women's as well. In addition to his medical degree, Dr. Flores also completed a clinical effectiveness program at Harvard's School of Public Health and received an M.S. in biostatistics from Columbia University.
Certified by the American Board of Surgery and the American Board of Thoracic Surgery, Flores has served as clinical assistant professor of cardiothoracic surgery, Cornell University Medical College, New York, and assistant professor of cardiothoracic surgery at the same institution. In addition to speaking English, Dr. Flores is fluent in both Spanish and Arabic, allowing him to more easily serve the diverse population of the New York City metropolitan area.
Flores indicates that his clinical interests include not only the surgical treatment of mesothelioma but also lung cancer screening, thorascopy, VATS lobectomy, intraoperative chemotherapy, and tracheal, carinal, and esophageal surgery.
As a researcher, Dr. Flores has participated in and led many clinical trials, including several involving the study and treatment of malignant mesothelioma. Recent trials include a large study that involved the use of neoadjuvant gemcitabine and cisplatin followed by extrapleural pneumonectomy and high dose radiation for the treatment of malignant mesothelioma patients, and another which examined the use of neoadjuvant Alimta/cisplatin, extrapleural pneumonectomy, and high dose radiation to treat mesothelioma. Another trial led by Flores, focusing on the largest series of cases comparing extrapleural pneumonectomy to pleurectomy decortication, was recently profiled in The Journal of Thoracic and Cardiovascular Surgery. Flores and his research colleagues have contributed to many other peer-reviewed journals as well.
Affiliations and Awards
Dr. Flores is very active in a number of professional organizations, some of which have honored him with merit awards. These organizations include the American Association for Thoracic Surgery (AATS), The Society of Thoracic Surgeons (STS), General Thoracic Surgical Club, Cardiothoracic Surgery Network, European Society of Thoracic Surgeons (ESTS), and the International Society for Minimally Invasive Cardiothoracic Surgery. He currently serves on the AATS/STS Joint Workforce on New Technology and the Ad Hoc Committee for Technical Advancement for the ESTS.
Author: Linda Molinari
Editor in Chief, Mesothelioma Cancer AllianceRead about Linda
Reviewer: Annette Charlevois
Patient Support CoordinatorRead about Annette
Mount Sinai School of Medicine Dept. of Thoracic Surgery